|
Fig 2. Adenoviral i-eag domains restore slow deactivation in HEK293 cells.Representative tail current recordings from HEK293 cells expressing: A, WT hERG1a.Ad; B, hERG1a(R56Q).Ad; C, hERG1a(R56Q).Ad + i-eag.Ad. Inset represents the voltage protocol used. D, Tail currents were fit with a double exponential function and the mean Ïfast (top) and Ïslow (bottom) values were plotted against voltage on a logarithmic scale. All values were plotted as mean ± S.E.M; n = 6â8 cells.
|
|
Fig 3. Adenoviral i-eag domains regulated the hERG R56Q current recorded with an AP waveform command.Representative current recordings: A (top) from WT hERG1a (black), hERG1a R56Q (red), and hERG R56Q + i-eag (blue) elicited with a voltage command mimicking a ventricular action potential A (bottom). B, Tail currents were generated by a step to â100 from 60 mV from same cells as in A). Double exponential fits (red traces) were extrapolated back to the moment of voltage change to obtain the peak tail current value (arrow). C, Box plot of peak currents elicited with AP command voltage (as in A) were normalized to peak tail current (as in B) to normalize for variations in channel expression between cells. D, Box plot of the time of the peak current elicited with the AP command voltage. For box plots, the middle line is the mean, the top and bottom lines are the 75th and 25th percentiles, respectively, and the straight lines are the 90th and 10th percentiles. n = 6â9 cells.E, Plot of currents in A) versus AP command voltage.
|
|
Fig 4. Adenoviral i-eag domains rescued the gating-deficiencies of hERG1a(R56Q) channels expressed in hiPSC-CMs.Voltage-clamp recordings of hERG currents measured from hiPSC-CMs infected by: A, WT hERG1a.Ad; B, hERG1a(R56Q).Ad; C, hERG1a(R56Q).Ad + i-eag.Ad. Inset represents the protocol used. D, I-V relationships for WT hERG1a.Ad, hERG1a(R56Q).Ad and hERG1a(R56Q).Ad + i-eag.Ad. The current at the end of depolarizing step was normalized to the maximum tail current and plotted versus voltage. All values were plotted as mean ± S.E.M; n> = 15 cells.
|
|
Fig 5. Adenoviral i-eag domains restored slow deactivation in hiPSC-CMs.Representative tail currents recorded from hiPSC-CMs infected by: A, WT hERG1a.Ad; B, hERG1a(R56Q).Ad; C, hERG1a(R56Q).Ad + i-eag.Ad. Inset represents the voltage protocol used. D, Tails were fit with a double exponential function, and mean Ïfast (top) and Ïslow (bottom) values were plotted against voltage on a logarithmic scale. All values were plotted as mean ± S.E.M.; n> = 15 cells.
|
|
Fig 6. hERG currents were isolated as E-4031 sensitive current.hERG currents overexpressed in hiPSC-CMs were isolated as E-4031-sensitive currents. A,B,C, The data showed families of current traces for WT hERG1a.Ad, hERG1a(R56Q).Ad and hERG1a(R56Q) + i-eag.Ad (top), after the addition of E4031(500 μM; Middle), and digitally subtracted traces to give the E-4031 sensitive currents (bottom). D, I-V relationships for each hERG channel above. The current at the end of depolarizing step was normalized to the maximum tail current and plotted versus voltage. E, Steady-state activation curves for each hERG channel above. All values were plotted as mean ± S.E.M.; n> = 15 cells.
|
|
Fig 7. FRET between i-eag domains and hERG R56Q channels in hiPSCs.Images of cells: A, hERG1a(R56Q).Citrine.Ad; B, hERG1a(R56Q).Citrine.Ad + i-eag.CFP.Ad. C, Determination of Ratio A0. The emission spectra from hiPSCs expressing hERG1a(R56Q).Citrine was determined with excitation at 436 nm and 500 nm. Ratio A0 is the F436 spectra normalized to F500 spectra. D, Spectra method for measuring FRET and determining Ratio A. Spectra (dark blue trace) was measured from cells coexpressing i-eag.CFP.Ad + hERG1a(R56Q).Citrine.Ad by excitation at 436nm. Emission spectra of CFP (cyan) were measured in a control experiment from hiPSCs expressing i-eag.CFP. Extracted spectra (F436, red trace) is the cyan spectra subtracted from the dark blue trace and contains the emission of Citrine. Spectrum (F500, black trace) was measured from excitation of Citrine at 500 nm. Ratio A is the F436 spectra normalized to F500 spectra. E, Bar graph of Ratio A- Ratio A0, a value directly related to FRET efficiency. n = 7â9 cells. *p<0.05 for FRET between hERG1a(R56Q) and i-eag-CFP domains compared to hERG1a and i-eag-CFP control.
|
|
Fig 8. i-eag domains regulate action potentials.Current clamp recording of action potentials from hiPSC-CMs expressing WT hERG1a.Ad, hERG1a(R56Q).Ad and hERG1a(R56Q).Ad + i-eag.Ad. A, hERG1a(R56Q) increased the action potential duration (*p <0.05 compared to WT hERG1a.Ad). B, Coexpression of i-eag.Ad decreased the action potential duration in cells with hERG1a(R56Q) (*p <0.05 compared to hERG1a(R56Q).Ad). C, Histogram of APD90 values in hiPSC-CMs infected by WT hERG1a.Ad, hERG1a(R56Q).Ad, and hERG1a(R56Q).Ad + i-eag.Ad. n = 12 for each. Scale bar is 50 s and 20 mV.
|
|
Fig 1. Adenoviral i-eag domains rescue the gating-deficiencies of hERG1a(R56Q) channels expressed in HEK293 cells.
A, Schematic depicting hERG channel subunit: a, WT hERG1a; b, hERG1a(R56Q); c, hERG1a(R56Q) + i-eag. B, C, D, Representative current recordings from HEK293 cells expressing: WT hERG1a.Ad, hERG1a(R56Q).Ad, hERG1a(R56Q).Ad + i-eag.Ad. Inset represents the voltage protocol used. E, IV relationships of WT hERG1a, hERG1a(R56Q), and hERG1a(R56Q).Ad + i-eag.Ad. The current at the end of the depolarizing step was normalized to the maximum tail current and plotted versus voltage. F, Representative steady-state inactivation current recording from WT hERG1a (top) using a three-pulse protocol (bottom). G, Steady-state activation and inactivation curves. Steady-state activation curves were generated by normalizing tail currents at -50 mV to the maximum tail current and plotted versus voltage. Steady-state inactivation curves were generated by normalizing the peak current and plotted versus voltage. Both steady-state activation and inactivation curves were fit with a Boltzmann function. All values were plotted as mean ± S.E.M; n = 5â13 cells.
|